- Home
- PSEC vs IRON Comparison
PSEC vs IRON Comparison
Compare PSEC & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSEC
- IRON
- Stock Information
- Founded
- PSEC 2004
- IRON 2017
- Country
- PSEC United States
- IRON United States
- Employees
- PSEC N/A
- IRON N/A
- Industry
- PSEC Finance/Investors Services
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- PSEC Finance
- IRON Health Care
- Exchange
- PSEC Nasdaq
- IRON Nasdaq
- Market Cap
- PSEC 1.9B
- IRON 1.9B
- IPO Year
- PSEC 2004
- IRON N/A
- Fundamental
- Price
- PSEC $4.10
- IRON $49.64
- Analyst Decision
- PSEC Sell
- IRON Strong Buy
- Analyst Count
- PSEC 1
- IRON 10
- Target Price
- PSEC $4.50
- IRON $83.80
- AVG Volume (30 Days)
- PSEC 2.7M
- IRON 373.9K
- Earning Date
- PSEC 05-07-2025
- IRON 05-08-2025
- Dividend Yield
- PSEC 15.37%
- IRON N/A
- EPS Growth
- PSEC N/A
- IRON N/A
- EPS
- PSEC N/A
- IRON N/A
- Revenue
- PSEC $796,249,000.00
- IRON N/A
- Revenue This Year
- PSEC N/A
- IRON N/A
- Revenue Next Year
- PSEC N/A
- IRON N/A
- P/E Ratio
- PSEC N/A
- IRON N/A
- Revenue Growth
- PSEC N/A
- IRON N/A
- 52 Week Low
- PSEC $4.00
- IRON $25.60
- 52 Week High
- PSEC $5.72
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- PSEC 31.97
- IRON 34.45
- Support Level
- PSEC $4.21
- IRON $51.57
- Resistance Level
- PSEC $4.28
- IRON $53.61
- Average True Range (ATR)
- PSEC 0.07
- IRON 2.13
- MACD
- PSEC -0.02
- IRON -0.13
- Stochastic Oscillator
- PSEC 30.28
- IRON 19.30
About PSEC Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.